close

Enter

Log in using OpenID

Sleep Evaluation Devices Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 2019 to 2026

embed
Global sleep evaluation market to value over US$ 7 billion by 2026, and register a CAGR of over 10% during 2019-2024. To collect information, record and analyse sleep schedules has always been an important element in medical sciences. The laborator
Sleep Evaluation Devices Market Global Trends, Market Share, Industry Size,
Growth, Opportunities, and Market Forecast 2019 to 2026
Global sleep evaluation market to value over US$ 7 billion by 2026, and register a
CAGR of over 10% during 2019-2024.
To collect information, record and analyse sleep schedules has always been an
important element in medical sciences. The laboratory polysomnography has been
the set standard to analyse sleeping pattern. There was a wide scope to explore the
domain of portable monitoring devices that assess sleep schedules in real-world
environments. These portable instruments allow easy data collection and recognise
patterns. The portable devices incorporate technology such as touch-free life care
system, Bioharness, health vest (smart life tech), Radiofrequency monitor, smart
shirt, wrist device (AMON) and Zio, etc.
The most common sleeping disorder is Apnea which raised more concern and
demand for the products of this specific market. It is a disorder where the body and
brain receive insufficient oxygen and breathing process is disrupted during sleep.
Obstructive Sleep Apnea (OSA) is the most common form of apnea which is caused
by blockage of the air passage. In order to prevent this and find a cure, it is necessary
for patients to undergo diagnostic tests and use therapeutic devices for complete
analysis and severity of the problem. This disorder is prevalent in the elderly
population, giving the geriatric tendency, and remains underdiagnosed owing to
factors like lack of awareness and non-specific presentation of the disease.
The initiatives to make the public more aware and increasing prevalence of sleep
disorders along with the need for the efficient diagnosis will promote revenue
growth. Introduction of technological advancements in the sphere of patient safety is
expected to increase device reach and business especially in the developed markets
of North America. High market penetration along with new government initiatives
aimed at minimising healthcare expenditure are some factors expected to drive
regional market growth during the forecast period.
The National Healthy Sleep Awareness Project states that obstructive sleep disorders
affect more than 25 million people in the U.S. and is a chronic disease that adversely
affects public health and is a primary health concern. The major factors driving the
growth of the sleep evaluation devices market are primarily a large pool of
undiagnosed sleep apnea patients, growing awareness about the ill effects of
untreated sleep apnea, technological advancements in manufacturing devices,
considerable venture capital funding, and an increasing number of companies
venturing into sleep apnea and oral appliances markets.
Sleep disorders increase with an increase in age. According to estimates published in
2012 by the UN, the global geriatric population was nearly 809.4 million and is
expected to grow more than double by 2050. Thus the patients affected by sleep
disorders is also expected to increase leading to demand sleep evaluation devices as
well.
Request a Sample Report @ https://www.futurewiseresearch.com/requestsample.aspx?id=218&page=requestsample
Sleep Evaluation Devices Market: Restraints
+ Lack of Awareness
+ General Ignorance
+ Non-specification of Disorders
Sleep Evaluation Devices Market Segmentation
By Product Type
+ Polysomnography Device
+ CPAP/BiPAP devices
+ ECG Devices
+ Pulse Oximeter
+ Snore microphone
+ Electroencephalogram
By End User
+ Hospitals
+ Sleep Centres
+ Clinics
+ Others
On the basis of end user, the sleep apnea devices market has been segmented into
sleep laboratories & hospitals and home care settings/individuals. The sleep
laboratories & hospitals segment accounted for the largest share of the market in
2018, while home care settings/individuals end-user segment is projected to grow at
the highest CAGR during the forecast period. This high growth is likely driven by
factors such as the rising preference for home sleep testing by both patients and
private insurance companies, along with the favourable reimbursement scenario for
home sleep testing.
By Region
+ North America
+ Latin America
+ Europe
+ Asia Pacific
+ Rest of the World
In 2018, North America accounted for the largest share of the global sleep evaluation
devices market, whereas, the Asia Pacific region is predicted to register the highest
CAGR during the forecast period. North American accounted for the largest share
owing to factors like an increase in the number of patients, growth in awareness
initiatives being taken by various government and non-government organizations,
availability of adequate funding for research and development.
Purchase a Copy of this Premium Research Report & Ask For Discount:
https://www.futurewiseresearch.com/requestsample.aspx?id=218&page=askfordiscount
Competitive Landscape:
+ Tier 1 players- established companies in the market with a major market share
+ Tier 2 players- Emerging players which are growing rapidly
+ New Entrants
Sleep Evaluation Devices market players include Allengers, Somno Medics, Cadwell,
Natus, CleveMed, Medatec, Nox Medical, Neurosoft, and others
The stringent regulations to be followed in the manufacturing of these devices has
created entry barriers for new firms. There exists a fierce competition among already
established market players, who are focused on expanding their geographic reach
and strengthen their customer database through new product development.
FutureWise Key Takeaways
+ Growth prospects
+ SWOT analysis
+ Key trends
+ Key data-points affecting market growth
Objectives of the Study:
+ To provide with an exhaustive analysis on the global Sleep Evaluation Devices
Market by Product Type, by End-User, and by Region
+ To cater comprehensive information on factors impacting market growth (drivers,
restraints, opportunities, and industry-specific restraints)
+ To evaluate and forecast micro-markets and the overall market
+ To predict the market size, in key regions (along with countries)—North America,
Europe, Asia Pacific, Latin America, and the Middle East
+ To record evaluate and competitive landscape mapping- product launches,
technological advancements, mergers and expansions
+ Profiling of companies to evaluate their market shares, strategies, financials and
core competencies
Table of Contents
1.1. Introduction
1.1.1.1. Scope and Objective
1.1.1.2. Assumptions and Acronyms
1.1.1.3. Forecast Factors
1.1.1.4. Research Methodology
1.2. Executive Summary
1.2.1.1. Industry Cluster Analysis
1.2.1.2. Competition Matrix
1.2.1.3. Strategies Recommendations
1.3. Market Definition
1.3.1.1. Report Scope (Inclusions & Exclusions)
1.3.1.2. Market Segmentation
1.4. Global Sleep Evaluation Devices Market Overview
1.4.1.1. Global Sleep Evaluation Devices Market Revenue (USD Mn)
1.5. Key Inclusions
1.5.1.1. Porter’s Five Force analysis
1.5.1.2. Market Dynamics
1.5.1.3. Industry Trends
1.5.1.4. Regulatory Guidelines
1.5.1.5. Opportunities in Sleep Evaluation Devices
1.6. Competition Dynamics
1.6.1.1. Company Share Analysis (2018)
1.6.1.2. Top 10 Product Pricing by Region
1.7. Global Sleep Evaluation Devices Market Revenue (USD Mn), 2018-2026 by
Product Type
1.7.1.1. Key Market Findings
1.7.1.2. Long Term ROI Segments
1.7.1.3. Revenue Opportunity Influencing Factors
1.7.1.4. Market Revenue (USD Mn) Assessment and Forecast by Product
Type, 2018-2026
1.7.1.4.1.1.
Polysomnography Device
1.7.1.4.1.2.
CPAP/biPAP devices
1.7.1.4.1.3.
ECG Devices
1.7.1.4.1.4.
Pulse Oximeter
1.7.1.4.1.5.
Snore microphone
1.7.1.4.1.6.
Electroencephalogram
1.8. Global Sleep Evaluation Devices Market Revenue (USD Mn), 2018-2026 by
End User
1.8.1.1. Key Market Findings
1.8.1.2. Long Term ROI Segments
1.8.1.3. Revenue Opportunity Influencing Factors
1.8.1.4. Market Revenue (USD Mn) Assessment and Forecast by End
User, 2018-2026
1.8.1.4.1.1.
Hospitals
1.8.1.4.1.2.
Sleep Centres
1.8.1.4.1.3.
Clinics
1.8.1.4.1.4.
Others
1.9. Global Sleep Evaluation Devices Market Revenue (USD Mn), 2018-2026 by
Region
1.9.1.1. Key Market Findings
1.9.1.2. Long Term ROI Segments
1.9.1.3. Revenue Opportunity Influencing Factors
1.9.1.4. Market Revenue (USD Mn) Assessment and Forecast by
Region,2026
1.9.1.4.1.1.
North America
1.9.1.4.1.2.
Latin America
1.9.1.4.1.3.
Europe
1.9.1.4.1.4.
Asia Pacific
1.9.1.4.1.5.
Rest of world
1.10.
North America Sleep Evaluation Devices Market Revenue (US$ Mn),
2018-2026
1.10.1.1. Key Market Findings
1.10.1.2. Long Term ROI Segments
1.10.1.3. Revenue Opportunity Influencing Factors
1.10.1.4. Market Revenue (USD Mn) Assessment and Forecast by Country,
2018-2026
1.10.1.4.1.1.
US
1.10.1.4.1.2.
Canada
1.10.1.5. Market Revenue (USD Mn) Assessment and Forecast by Product
Type, 2018-2026
1.10.1.5.1.1.
Polysomnography Device
1.10.1.5.1.2.
CPAP/biPAP devices
1.10.1.5.1.3.
ECG Devices
1.10.1.5.1.4.
Pulse Oximeter
1.10.1.5.1.5.
Snore microphone
1.10.1.5.1.6.
Electroencephalogram
1.10.1.6. Market Revenue (USD Mn) Assessment and Forecast by End
User, 2018-2026
1.10.1.6.1.1.
Hospitals
1.10.1.6.1.2.
Sleep Centres
1.10.1.6.1.3.
Clinics
1.10.1.6.1.4.
Others
1.11.
Latin America Sleep Evaluation Devices Market Revenue (US$ Mn),
2018-2026
1.11.1.1. Key Market Findings
1.11.1.2. Long Term ROI Segments
1.11.1.3. Revenue Opportunity Influencing Factors
1.11.1.4. Market Revenue (USD Mn) Assessment and Forecast by Country,
2018-2026
1.11.1.4.1.1.
Brazil
1.11.1.4.1.2.
Mexico
1.11.1.4.1.3.
Argentina
1.11.1.4.1.4.
Rest of Latin America
1.11.1.5. Market Revenue (USD Mn) Assessment and Forecast by Product
Type, 2018-2026
1.11.1.5.1.1.
Polysomnography Device
1.11.1.5.1.2.
CPAP/biPAP devices
1.11.1.5.1.3.
ECG Devices
1.11.1.5.1.4.
Pulse Oximeter
1.11.1.5.1.5.
Snore microphone
1.11.1.5.1.6.
Electroencephalogram
1.11.1.6. Market Revenue (USD Mn) Assessment and Forecast by End
User, 2018-2026
1.11.1.6.1.1.
Hospitals
1.11.1.6.1.2.
Sleep Centres
1.11.1.6.1.3.
Clinics
1.11.1.6.1.4.
Others
1.12.
Europe America Sleep Evaluation Devices Market Revenue (US$ Mn),
2018-2026
1.12.1.1. Key Market Findings
1.12.1.2. Long Term ROI Segments
1.12.1.3. Revenue Opportunity Influencing Factors
1.12.1.4. Market Revenue (USD Mn) Assessment and Forecast by Country,
2018-2026
1.12.1.4.1.1.
Germany
1.12.1.4.1.2.
France
1.12.1.4.1.3.
Spain
1.12.1.4.1.4.
UK
1.12.1.4.1.5.
Russia
1.12.1.4.1.6.
Poland
1.12.1.4.1.7.
Rest of Europe
1.12.1.5. Market Revenue (USD Mn) Assessment and Forecast by Product
Type, 2018-2026
1.12.1.5.1.1.
Polysomnography Device
1.12.1.5.1.2.
CPAP/biPAP devices
1.12.1.5.1.3.
ECG Devices
1.12.1.5.1.4.
Pulse Oximeter
1.12.1.5.1.5.
Snore microphone
1.12.1.5.1.6.
Electroencephalogram
1.12.1.6. Market Revenue (USD Mn) Assessment and Forecast by End
User, 2018-2026
1.12.1.6.1.1.
Hospitals
1.12.1.6.1.2.
Sleep Centres
1.12.1.6.1.3.
Clinics
1.12.1.6.1.4.
Others
1.13.
Asia Pacific America Sleep Evaluation Devices Market Revenue (US$
Mn), 2018-2026
1.13.1.1. Key Market Findings
1.13.1.2. Long Term ROI Segments
1.13.1.3. Revenue Opportunity Influencing Factors
1.13.1.4. Market Revenue (USD Mn) Assessment and Forecast by Country,
2018-2026
1.13.1.4.1.1.
Emerging Asia
1.13.1.4.1.1.1.1. China
1.13.1.4.1.1.1.2. India
1.13.1.4.1.1.1.3. ASEAN-5
1.13.1.4.1.1.1.4. Rest of Emerging Asia
1.13.1.4.1.2.
Japan
1.13.1.5. Market Revenue (USD Mn) Assessment and Forecast by Product
Type, 2018-2026
1.13.1.5.1.1.
Polysomnography Device
1.13.1.5.1.2.
CPAP/biPAP devices
1.13.1.5.1.3.
ECG Devices
1.13.1.5.1.4.
Pulse Oximeter
1.13.1.5.1.5.
Snore microphone
1.13.1.5.1.6.
Electroencephalogram
1.13.1.6. Market Revenue (USD Mn) Assessment and Forecast by End
User, 2018-2026
1.13.1.6.1.1.
Hospitals
1.13.1.6.1.2.
Sleep Centres
1.13.1.6.1.3.
Clinics
1.13.1.6.1.4.
Others
1.14.
Rest of World America Sleep Evaluation Devices Market Revenue (US$
Mn), 2018-2026
1.14.1.1. Key Market Findings
1.14.1.2. Long Term ROI Segments
1.14.1.3. Revenue Opportunity Influencing Factors
1.14.1.4. Market Revenue (USD Mn) Assessment and Forecast by Country,
2018-2026
1.14.1.4.1.1.
Middle East
1.14.1.4.1.2.
South Africa
1.14.1.4.1.3.
North Africa
1.14.1.4.1.4.
Rest of World
1.14.1.5. Market Revenue (USD Mn) Assessment and Forecast by Product
Type, 2018-2026
1.14.1.5.1.1.
Polysomnography Device
1.14.1.5.1.2.
CPAP/biPAP devices
1.14.1.5.1.3.
ECG Devices
1.14.1.5.1.4.
Pulse Oximeter
1.14.1.5.1.5.
Snore microphone
1.14.1.5.1.6.
Electroencephalogram
1.14.1.6. Market Revenue (USD Mn) Assessment and Forecast by End
User, 2018-2026
1.14.1.6.1.1.
Hospitals
1.14.1.6.1.2.
Sleep Centres
1.14.1.6.1.3.
Clinics
1.14.1.6.1.4.
Others
1.15.
Company Profiles
1.15.1.1. Competition Landscape
1.15.1.2. Global Company Share (USD Mn) Overview, 2018
1.15.1.3. Company Profiles
1.15.1.3.1.1.
Allengers
1.15.1.3.1.1.1.1. Corporate Overview
1.15.1.3.1.1.1.2. Financial Performance
1.15.1.3.1.1.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.1.1.4. Company Strategy & Channel Management
1.15.1.3.1.2.
Somno Medics
1.15.1.3.1.2.1.1. Corporate Overview
1.15.1.3.1.2.1.2. Financial Performance
1.15.1.3.1.2.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.2.1.4. Company Strategy & Channel Management
1.15.1.3.1.3.
Cadwell
1.15.1.3.1.3.1.1. Corporate Overview
1.15.1.3.1.3.1.2. Financial Performance
1.15.1.3.1.3.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.3.1.4. Company Strategy & Channel Management
1.15.1.3.1.4.
Natus
1.15.1.3.1.4.1.1. Corporate Overview
1.15.1.3.1.4.1.2. Financial Performance
1.15.1.3.1.4.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.4.1.4. Company Strategy & Channel Management
1.15.1.3.1.5.
CleveMed
1.15.1.3.1.5.1.1. Corporate Overview
1.15.1.3.1.5.1.2. Financial Performance
1.15.1.3.1.5.1.3. Peer Comparison & 3C marketing equation
1.16.
1.15.1.3.1.5.1.4. Company Strategy & Channel Management
1.15.1.3.1.6.
Medatec
1.15.1.3.1.6.1.1. Corporate Overview
1.15.1.3.1.6.1.2. Financial Performance
1.15.1.3.1.6.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.6.1.4. Company Strategy & Channel Management
1.15.1.3.1.7.
Nox Medical
1.15.1.3.1.7.1.1. Corporate Overview
1.15.1.3.1.7.1.2. Financial Performance
1.15.1.3.1.7.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.7.1.4. Company Strategy & Channel Management
1.15.1.3.1.8.
Neurosoft
1.15.1.3.1.8.1.1. Corporate Overview
1.15.1.3.1.8.1.2. Financial Performance
1.15.1.3.1.8.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.8.1.4. Company Strategy & Channel Management
Research Sources & Primary Verbatim
Inquire further details about this report at: [email protected]
About FutureWise Research:
We specialise in high-growth niche markets, assuring flexibility, agility and
customised solutions for our clients. Through in-depth market insights and
consultancy, we present our clients with the tools they need to be at the forefront of
their industry – a position secured for far more than the near future.
Contact Us:
Company Name: FutureWise Research
Contact Person: Vinay Thaploo
Email: [email protected]
Phone: +44 141 628 9353 / +1 970 279 4295
City: Leeds
Country: United Kingdom
Website: www.futurewiseresearch.com
1/--pages
Report inappropriate content